A Metabolomic Approach Applied to a Liquid Chromatography Coupled to High‐Resolution Tandem Mass Spectrometry Method (HPLC‐ESI‐HRMS/MS): Towards the Comprehensive Evaluation of the Chemical Composition of Cannabis Medicinal Extracts
- 15 September 2017
- journal article
- research article
- Published by Wiley in Phytochemical Analysis
- Vol. 29 (2), 144-155
- https://doi.org/10.1002/pca.2722
Abstract
Cannabis sativa L. is a powerful medicinal plant and its use has recently increased for the treatment of several pathologies. Nonetheless, side effects, like dizziness and hallucinations, and long-term effects concerning memory and cognition, can occur. Most alarming is the lack of a standardised procedure to extract medicinal cannabis. Indeed, each galenical preparation has an unknown chemical composition in terms of cannabinoids and other active principles that depends on the extraction procedure. This study aims to highlight the main differences in the chemical composition of Bediol® extracts when the extraction is carried out with either ethyl alcohol or olive oil for various times (0, 60, 120 and 180 min for ethyl alcohol, and 0, 60, 90 and 120 min for olive oil). Methodology. Cannabis medicinal extracts (CMEs) were analysed by liquid chromatography coupled to high-resolution tandem mass spectrometry (LC–MS/MS) using an untargeted metabolomics approach. The data sets were processed by unsupervised multivariate analysis. Our results suggested that the main difference lies in the ratio of acid to decarboxylated cannabinoids, which dramatically influences the pharmacological activity of CMEs. Minor cannabinoids, alkaloids, and amino acids contributing to this difference are also discussed. The main cannabinoids were quantified in each extract applying a recently validated LC–MS and LC-UV method. Notwithstanding the use of a standardised starting plant material, great changes are caused by different extraction procedures. The metabolomics approach is a useful tool for the evaluation of the chemical composition of cannabis extracts. Copyright © 2017 John Wiley & Sons, Ltd.Keywords
This publication has 45 references indexed in Scilit:
- Liquid chromatography quadrupole time-of-flight mass spectrometry characterization of metabolites guided by the METLIN databaseNature Protocols, 2013
- The Pharmacologic and Clinical Effects of Medical CannabisPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013
- A cross-platform toolkit for mass spectrometry and proteomicsNature Biotechnology, 2012
- Metabolic fingerprinting of Cannabis sativa L., cannabinoids and terpenoids for chemotaxonomic and drug standardization purposesPhytochemistry, 2010
- HU-331: a cannabinoid quinone, with uncommon cytotoxic properties and low toxicityExpert Opinion on Investigational Drugs, 2007
- Antitumor Activity of Plant Cannabinoids with Emphasis on the Effect of Cannabidiol on Human Breast CarcinomaThe Journal of pharmacology and experimental therapeutics, 2006
- Determination of cannabinoids in cannabis products using liquid chromatography–ion trap mass spectrometryJournal of Chromatography A, 2004
- Metabolomic Differentiation of Cannabis sativa Cultivars Using 1H NMR Spectroscopy and Principal Component AnalysisJournal of Natural Products, 2004
- A Comparison of the Ocular and Central Effects of Δ9-Tetrahydrocannabinol and CannabigerolJournal of Ocular Pharmacology and Therapeutics, 1990
- Tetrahydrocannabinolic Acid, a Genuine Substance of TetrahydrocannabinolCHEMICAL & PHARMACEUTICAL BULLETIN, 1967